Ephedra “Black Box” Warning Considered By FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA is suggesting that a "black box" warning appear on the principal display panel of all ephedrine alkaloid-containing dietary supplements, FDA Commissioner Mark McClellan, MD/PhD, said during a Feb. 28 briefing held in Washington, D.C
You may also be interested in...
Ephedra Rule Cites Lack Of Safety Data In Vulnerable Subjects
Research weighed by FDA in evaluating the safety of ephedrine alkaloid-containing dietary supplements was lacking in subjects that were adequately representative of the broader population, the agency maintains in the 1final rule banning the botanical
Ephedra Rule Cites Lack Of Safety Data In Vulnerable Subjects
Research weighed by FDA in evaluating the safety of ephedrine alkaloid-containing dietary supplements was lacking in subjects that were adequately representative of the broader population, the agency maintains in the 1final rule banning the botanical
Ephedra Rule Cites Lack Of Safety Data In Vulnerable Subjects
Research weighed by FDA in evaluating the safety of ephedrine alkaloid-containing dietary supplements was lacking in subjects that were adequately representative of the broader population, the agency maintains in the 1final rule banning the botanical